Coherus BioSciences surges on FDA Udenyca delivery system approval By Investing.com

<p> <br />
</p>
<div>
<div>
<img decoding="async" alt="Coherus BioSciences surges on FDA Udenyca delivery system approval" id="carouselImage" src="https://i-invdn-com.investing.com/news/LYNXNPEC0L0PD_L.jpg" style="visibility:hidden" /><br />
<span>© Reuters. Coherus BioSciences (CHRS) surges on FDA Udenyca delivery system approval</span><br />
<i class="imgGrad"/>
</div>
<p>Shares of Coherus BioSciences (CHRS) surged 35% in premarket trading on Wednesday after the company announced the U.S. Food and Drug Administration (FDA) approved its UDENYCA ONBODY product.</p>
<p>UDENYCA ONBODY is the company’s on-body injector (OBI) presentation of UDENCYA, designed for a five-minute injection time. The device features an automatic retractable needle mechanism.</p>
<p>“The on-body injector for UDENYCA is the result of years of significant investment in research and development to bring forward a novel and proprietary device that provides patients with an automatic delivery option for their medication,” said Denny Lanfear, CEO of Coherus. </p>
<p>Paul Reider, Coherus’s chief commercial officer, said: “Our market studies showed a significant demand for a novel on-body pegfilgrastim delivery device tailored to specific patient needs. We expect that UDENYCA ONBODY’s five-minute injection time and innovative retractable needle mechanism will be well received by cancer patients, their caregivers, and doctors.”</p>
<p>Coherus said it conducted extensive market research, revealing a strong demand for the system. </p>
<p>The company’s shares are trading just below the $3 per share mark ahead of Wednesday’s open. </p>
</div>
<p><br />
<br /><a href="https://www.investing.com/news/stock-market-news/coherus-biosciences-surges-on-fda-udenyca-delivery-system-approval-432SI-3263991">Source link </a></p><p>The post <a href="https://forextraderhub.com/coherus-biosciences-surges-on-fda-udenyca-delivery-system-approval-by-investing-com.html">Coherus BioSciences surges on FDA Udenyca delivery system approval By Investing.com</a> first appeared on <a href="https://forextraderhub.com">Forex Trader Hub</a>.</p>